X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (260) 260
index medicus (185) 185
female (145) 145
hematology (132) 132
male (119) 119
peripheral vascular disease (105) 105
middle aged (94) 94
adult (87) 87
aged (72) 72
anticoagulants (66) 66
anticoagulants - adverse effects (64) 64
anticoagulants - therapeutic use (63) 63
heparin - adverse effects (62) 62
heparin-induced thrombocytopenia (61) 61
thrombosis (56) 56
risk factors (55) 55
thrombocytopenia - chemically induced (55) 55
heparin (54) 54
rivaroxaban (47) 47
molecular-weight heparin (45) 45
venous thromboembolism (42) 42
anticoagulants - administration & dosage (41) 41
pregnancy (34) 34
risk (34) 34
surgery (33) 33
antibodies (32) 32
dabigatran (32) 32
diagnosis (32) 32
medicine, general & internal (31) 31
thromboembolism (31) 31
treatment outcome (31) 31
aged, 80 and over (30) 30
cardiac & cardiovascular systems (30) 30
therapy (30) 30
thrombocytopenia (30) 30
fondaparinux (29) 29
management (29) 29
unfractionated heparin (29) 29
deep-vein thrombosis (27) 27
medicine & public health (27) 27
venous thrombosis (24) 24
abridged index medicus (23) 23
prevention (23) 23
warfarin (23) 23
cardiology (22) 22
thrombin (22) 22
administration, oral (21) 21
adolescent (21) 21
pharmacology & pharmacy (21) 21
ticlopidine - analogs & derivatives (21) 21
blood coagulation - drug effects (20) 20
follow-up studies (20) 20
internal medicine (20) 20
retrospective studies (20) 20
thrombocytopenia - diagnosis (20) 20
thrombophilia (20) 20
animals (19) 19
clopidogrel (19) 19
pharmacokinetics (19) 19
platelet aggregation inhibitors - therapeutic use (19) 19
prospective studies (19) 19
time factors (19) 19
young adult (19) 19
allergy (18) 18
analysis (18) 18
anticoagulation (18) 18
coagulation assays (18) 18
induced thrombocytopenia (18) 18
platelet factor 4 - immunology (18) 18
risk-factors (18) 18
hematology, oncology and palliative medicine (17) 17
hemorrhage - chemically induced (17) 17
heparin - immunology (17) 17
pharmacodynamics (17) 17
prevalence (17) 17
pulmonary embolism (17) 17
thrombocytopenia - immunology (17) 17
danaparoid (16) 16
drug therapy (16) 16
medical research (16) 16
platelet count (16) 16
pulmonary-embolism (16) 16
reproducibility of results (16) 16
ticlopidine - therapeutic use (16) 16
apixaban (15) 15
cardiopulmonary bypass (15) 15
coagulation (15) 15
factor xa inhibitors (15) 15
heparin - therapeutic use (15) 15
medicine, experimental (15) 15
platelets (15) 15
sensitivity and specificity (15) 15
activation (14) 14
aspirin (14) 14
care and treatment (14) 14
incidence (14) 14
patients (14) 14
platelet activation (14) 14
resistance (14) 14
thrombocytopenia - drug therapy (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Der Internist, ISSN 0020-9554, 06/2019, Volume 60, Issue 6, pp. 644 - 655
Journal Article
Der Internist, ISSN 0020-9554, 06/2019, Volume 60, Issue 6, p. 644
Die Virchow-Trias ist seit 100 Jahren bekannt. Die Entwicklung der therapeutischen Moglichkeiten in dieser Zeit war enorm. Heute ist die Antikoagulation viel... 
Journal Article
Phlebologie, ISSN 0939-978X, 12/2018, Volume 47, Issue 6, pp. 344 - 351
Zusammenfassung Durch eine weltweit alternde Bevölkerung nehmen Vorhofflimmern und venöse Thromboembolien und dadurch auch der Einsatz direkter oraler... 
Übersichtsarbeiten
Journal Article
Der Internist, 06/2019, Volume 60, Issue 6, p. 644
Virchow's triad has been known for a 100 years. The development of therapeutic possibilities during this time was enormous. Today anticoagulant therapy is much... 
Journal Article
Phlebologie, ISSN 0939-978X, 2018, Volume 47, Issue 6, pp. 344 - 351
Journal Article
Gefässchirurgie, ISSN 0948-7034, 2/2016, Volume 21, Issue 1, pp. 1 - 3
Journal Article
Gefasschirurgie, ISSN 0948-7034, 02/2016, Volume 21, Issue 1, p. 1
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00772-015-0098-2 
Journal Article
HAMOSTASEOLOGIE, ISSN 0720-9355, 2017, Volume 37, Issue 4, pp. 257 - 266
The worldwide increase in the aging population and the associated increase in the prevalence of atrial fibrillation and venous thromboembolism as well as the... 
emergency operation | direct oral anticoagulants | life-threatening bleeding | ANDEXANET ALPHA | FACTOR VIIA | RIVAROXABAN | EDOXABAN | FACTOR XA INHIBITORS | REVERSAL | antidotes | DABIGATRAN | prothrombin complex concentrate (PCC) | WARFARIN | PROTHROMBIN COMPLEX CONCENTRATE | COAGULATION | reversal agents | HEMATOLOGY
Journal Article
Thrombosis Research, ISSN 0049-3848, 2010, Volume 126, Issue 6, pp. e428 - e433
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2018, Volume 71, Issue 15, pp. 1710 - 1712
[...]data must be interpreted with caution in regard to causality and outcome prediction by differences in baseline characteristics. [...]an analysis of... 
CARDIAC & CARDIOVASCULAR SYSTEMS | OFF-LABEL | Hypertension | Laboratories
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 04/2008, Volume 6, Issue 4, pp. 677 - 683
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2013, Volume 109, Issue 1, pp. 127 - 136
Summary Global coagulation assays display variable effects at different concentrations of rivaroxaban. The aim of this study is to quantify the ex vivo effects... 
New Technologies, Diagnostic Tools and Drugs | Von Willebrand disease | Lupus anticoagulants | Rivaroxaban | D-dimer | Protein C | Protein S | Clotting factor activity | BAY-59-7939 | rivaroxaban | PHARMACODYNAMICS | TIME | protein S | lupus anticoagulants | FACTOR-XA INHIBITOR | PHARMACOKINETICS | von Willebrand disease | PERIPHERAL VASCULAR DISEASE | LUPUS ANTICOAGULANT | protein C | HEMATOLOGY | Predictive Value of Tests | Anticoagulants - administration & dosage | Arthroplasty, Replacement, Knee - adverse effects | Factor Xa Inhibitors | Tablets | Humans | Thiophenes - administration & dosage | Chromatography, High Pressure Liquid | False Positive Reactions | Tandem Mass Spectrometry | Thrombophilia - diagnosis | Time Factors | Blood Coagulation Tests - methods | Thrombosis - blood | Thrombosis - prevention & control | Nephelometry and Turbidimetry | Reproducibility of Results | Drug Administration Schedule | Enzyme-Linked Immunosorbent Assay | Administration, Oral | Morpholines - administration & dosage | Treatment Outcome | Biomarkers - blood | Blood Coagulation Factors - metabolism | Arthroplasty, Replacement, Hip - adverse effects | Factor Xa - metabolism | Blood Coagulation - drug effects | Thrombophilia - blood | Thrombosis - etiology | Blood Coagulation Factors - antagonists & inhibitors | Chromogenic Compounds | Thrombosis - diagnosis
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 06/2014, Volume 2014, Issue default, pp. 789 - 798
Helen Mani, Edelgard Lindhoff-LastJohann Wolfgang Goethe-University Hospital Frankfurt/Main, Department of Internal Medicine, Division of Haemostasis,... 
Journal Article
Journal Article
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie, ISSN 0044-409X, 12/2013, Volume 138, Issue S 02, pp. e86 - e94
Zusammenfassung Zentralvenöse Zugangswege werden mit zunehmender Häufigkeit in der Therapie akuter und chronischer Erkrankungen eingesetzt. Katheterassoziierte... 
Übersicht | treatment | central venous catheter | occlusion | upper extremity deep vein thrombosis
Journal Article
ZENTRALBLATT FUR CHIRURGIE, ISSN 0044-409X, 12/2013, Volume 138, pp. E86 - E94
Central venous catheters (CVCs) are important tools in the care of patients with acute or chronic diseases, but catheter-related thrombosis and thrombotic... 
SURGERY | treatment | ADULT PATIENTS | RISK-FACTORS | upper extremity deep vein thrombosis | ACCESS DEVICES | PREVENTION | central venous catheter | FACTOR-V-LEIDEN | CANCER-PATIENTS | occlusion | MOLECULAR-WEIGHT HEPARIN | DOUBLE-BLIND | COMPLICATIONS | CENTRAL VENOUS CATHETERS
Journal Article
Der Internist, ISSN 0020-9554, 10/2014, Volume 55, Issue 10, pp. 1139 - 1148
Pathologische Gerinnungsparameter können eine lebensbedrohliche hämorrhagische oder thrombembolische Erkrankung anzeigen, einen Laborbefund ohne klinische... 
Blutgerinnungstests | Thrombocytopenia | Nephrology | Thrombozytose | General Practice / Family Medicine | Internal Medicine | Hyperfibrinogenämie | Hyperfibrinogenemia | Thrombozytopenie | Medicine & Public Health | Hypofibrinogenemia | Hepatology | Gastroenterology | Hypofibrinogenämie | Thrombocytosis | Blood coagulation tests | Cardiology
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.